Robotics in Cell Therapy Manufacturing Market Size, Share, Revenue Report 2026 to 2035
What is Robotics in Cell Therapy Manufacturing Market Size?
Global Robotics in Cell Therapy Manufacturing Market Size is valued at USD 1.68 Bn in 2025 and is predicted to reach USD 6.38 Bn by the year 2035 at a 14.5% CAGR during the forecast period for 2026 to 2035.
Robotics in Cell Therapy Manufacturing Market Size, Share & Trends Analysis Report By Component (Hardware, Software, Services); By Cell Type (T-cells, Stem cells, Natural Killer Cells, Other cell types); By Manufacturing Process Stage (Upstream Processing, Downstream Processing, Fill-Finish Operations, Quality Control (QC)); By Robotics Type (Industrial Robotics, Collaborative Robots, Fully Automated Closed Systems, AI-driven/Smart Robotics); By End-User (Pharmaceutical Companies, Biotechnology Companies, Contract Manufacturing Organizations (CMOs), Research Institutes, Academic Hospitals), and Segment Forecasts, 2026 to 2035
Robotics in cell therapy manufacturing involves the integration of advanced robotic systems, automation technologies, and intelligent process controls to streamline the production of cell-based therapies. These systems automate critical and labor-intensive steps, including cell isolation, expansion, harvesting, formulation, quality control testing, filling, and cryopreservation.
By replacing manual operations with high-precision robotic platforms, manufacturers can achieve superior batch-to-batch consistency, significantly reduce the risk of contamination, minimize human error, and ensure compliance with stringent Good Manufacturing Practice (GMP) and regulatory requirements. As cell and gene therapies advance from clinical trials toward commercial-scale production, robotics has become a critical enabler for improving manufacturing efficiency, scalability, product quality, and cost-effectiveness in this rapidly evolving sector.
The global robotics in cell therapy manufacturing market is showing rapid expansion owing to the rising amount of investment in regenerative medicine, increase in clinical trials, and approval of cell-based therapies all over the world. There is an investment in developing advanced manufacturing capabilities, thereby providing opportunities for automation technology. Additionally, the use of artificial intelligence, machine vision, and digital manufacturing systems is enabling companies to streamline their processes, thereby improving their efficiency and productivity.
Moreover, there is a trend towards closed-system manufacturing and smart bioprocessing facilities within the sector. Such trends are expected to improve reliability as well as accommodate the large-scale manufacturing needs of the next generation of cell therapies. With the demand for personalized medicine on the rise, robotics will play a pivotal role in future manufacturing.
Competitive Landscape
Which are the Leading Players in Robotics in Cell Therapy Manufacturing Market?
- Thermo Fisher Scientific Inc.
- Cytiva
- Lonza Group AG
- Sartorius AG
- Miltenyi Biotec
- Fresenius Kabi AG
- Danaher Corporation
- Cellares Corporation
- Multiply Labs
- Ori Biotech
- Cellino Biotech
- Terumo Corporation
- ABB Ltd.
- FANUC Corporation
- Yaskawa Electric Corporation
- Kawasaki Robotics
- Bio-Techne Corporation
- Catalent Inc.
- Fujifilm Holdings Corporation
- BioNTech SE
Market Dynamics :
Driver
Growing Commercialization of Cell and Gene Therapies
Increased commercialization of cell and gene therapies is likely to be one of the key factors driving the global robotics in cell therapy manufacturing market during the forecast period. The growing commercialization of advanced therapies is encouraging manufacturers to adopt more efficient and streamlined production methods. Furthermore, growing investment in regenerative medicine and personalized healthcare will fuel the deployment of automation technologies in manufacturing plants. With the help of robotics technology, manufacturers can ensure higher production rates along with quality standards. Regulatory approvals for various cell-based therapies will also contribute towards increased demand.
Restrain/Challenge
High Capital Investment and Manufacturing Complexity
Among the primary obstacles that are hindering the growth of the robotics in cell therapy manufacturing market is the high cost involved in incorporating automation technologies. There are several factors that make automation expensive and can therefore discourage smaller biotech firms from adopting robotics for cell therapy manufacturing. Besides the technical complexity of cell therapy manufacturing process that makes it unique and specialized, the incorporation of robotics technology into cell therapy manufacturing becomes difficult. Moreover, there could also be shortage of qualified workers due to limited number of experts who are experienced in robotic techniques and biomanufacturing technologies.
Biopharmaceutical Companies Segment is Expected to Drive the Robotics in Cell Therapy Manufacturing Market
The segment of biopharmaceutical companies had the maximum share in the market for robotics in the manufacturing of cell therapies in the year 2025. Growth in the number of commercial-stage cell therapies and increased investments in the infrastructure for manufacturing have compelled biopharmaceutical companies to embrace modern automation solutions. Robotics technology plays an important role in achieving process standardization, lowering costs, and meeting large-scale manufacturing requirements. In addition, manufacturers are using robotic systems to speed up development and increase manufacturing agility. With the growing pipeline of cell therapies, biopharmaceutical companies will continue to dominate the market over the forecast period.
Artificial Intelligence-Enabled Robotics Segment is Growing at the Highest Rate in the Robotics in Cell Therapy Manufacturing Market
In 2025, artificial intelligence-driven robotics will be the primary driver of market growth since it allows better process control, predictive maintenance, and decision making. AI-driven robotic systems can make analysis of vast quantities of data related to manufacturing processes in real-time for workflow optimization. With the growing popularity of machine learning, computer vision, and analytics applied to robots, the efficiency of the manufacturing process and final products will continue to increase. Organizations that strive for greater automation of their production facilities will increasingly use AI-based robotics solutions.
Why North America Led the Robotics in Cell Therapy Manufacturing Market?
North America held the majority share of the Robotics in Cell Therapy Manufacturing market in 2025, due to the high level of investment in biotechnology research, superior manufacturing capabilities, and supportive regulations. The presence of key players involved in cell therapies, contract manufacturing companies, and automation technologies has been contributing to the fast adoption of robots for manufacturing purposes.
Moreover, funding for regenerative medicine studies along with their commercialization efforts has led to an increased need for robotics technology. The US remains a prominent location for the development and manufacturing of cell therapies.
Key Developments
• In June 2025: Thermo Fisher Scientific partnered with Cellular Origins to combine Thermo Fisher's cell culture and processing technologies with the Constellation robotic manufacturing platform. The collaboration aims to enable fully automated, 24/7 robotic manufacturing of cell and gene therapies (CGTs) at industrial scale, reducing labor requirements and increasing manufacturing throughput.
Robotics in Cell Therapy Manufacturing Market Report Scope:
| Report Attribute | Specifications |
| Market size value in 2025 | USD 1.68 Bn |
| Revenue forecast in 2035 | USD 6.38 Bn |
| Growth Rate CAGR | CAGR of 14.5% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Component, Cell Type, Manufacturing Process Stage, Robotics Type, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Thermo Fisher Scientific Inc., Cytiva, Lonza Group AG, Sartorius AG, Miltenyi Biotec, Fresenius Kabi AG, Danaher Corporation, Cellares Corporation, Multiply Labs, Ori Biotech, Cellino Biotech, Terumo Corporation, ABB Ltd., FANUC Corporation, Yaskawa Electric Corporation, Kawasaki Robotics, Bio-Techne Corporation, Catalent Inc., Fujifilm Holdings Corporation, and BioNTech SE. |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentations of Robotics in Cell Therapy Manufacturing Market :
Robotics in Cell Therapy Manufacturing Market by Component -
- Hardware
- Software
- Services
Robotics in Cell Therapy Manufacturing Market by Cell Type -
- T-cells
- Stem cells
- Natural Killer Cells
- Other cell types
Robotics in Cell Therapy Manufacturing Market by Manufacturing Process Stage -
- Upstream Processing
- Downstream Processing
- Fill-Finish Operations
- Quality Control (QC)
Robotics in Cell Therapy Manufacturing Market by Robotics Type -
- Industrial Robotics
- Collaborative Robots
- Fully Automated Closed Systems
- AI-driven/Smart Robotics
Robotics in Cell Therapy Manufacturing Market by End-user -
- Pharmaceutical Companies
- Biotechnology Companies
- Contract Manufacturing Organizations (CMOs)
- Research Institutes
- Academic Hospitals
Robotics in Cell Therapy Manufacturing Market by Region-
- North America-
- The US
- Canada
- Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
- Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
- Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East and Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Robotics in Cell Therapy Manufacturing Market Size is valued at USD 1.68 Bn in 2025 and is predicted to reach USD 6.38 Bn by the year 2035 at a 14.5% CAGR during the forecast period for 2026 to 2035.
The Robotics in Cell Therapy Manufacturing Market is expected to grow at a 14.5% CAGR during the forecast period for 2026 to 2035
Thermo Fisher Scientific Inc., Cytiva, Lonza Group AG, Sartorius AG, Miltenyi Biotec, Fresenius Kabi AG, Danaher Corporation, Cellares Corporation, Multiply Labs, Ori Biotech, Cellino Biotech, Terumo Corporation, ABB Ltd., FANUC Corporation, Yaskawa Electric Corporation, Kawasaki Robotics, Bio-Techne Corporation, Catalent Inc., Fujifilm Holdings Corporation, BioNTech SE. and Others.
Robotics in Cell Therapy Manufacturing Market is segmented into Component, Cell Type, Manufacturing Process Stage, Robotics Type, End-user and Others.
North America region is leading the Robotics in Cell Therapy Manufacturing Market.